Global Rheumatoid Arthritis Drugs Market Size, Status and Forecast 2025

February 2018 | 102 pages | ID: GC366CD15B6EN
QYResearch

Abstracts

This report studies the global Rheumatoid Arthritis Drugs market, analyzes and researches the Rheumatoid Arthritis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Merck
• Novartis
• Pfizer
• J&J
• BMS
• Abbvie
• Boehringer Ingelheim
• AstraZeneca
• MedImmune
• Takeda
• Biogen Idec
• Celgene
• Bristol-Myers Squibb
• Celltrion

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, the product can be split into

• NSAIDs
• DMARDs
• Corticosteroids
• Analgesics
• Other

Market segment by Application, Rheumatoid Arthritis Drugs can be split into

• Hospitals
• Clinics
• Home Care
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Rheumatoid Arthritis Drugs Market Size, Status and Forecast 2025

1 INDUSTRY OVERVIEW OF RHEUMATOID ARTHRITIS DRUGS

1.1 Rheumatoid Arthritis Drugs Market Overview
  1.1.1 Rheumatoid Arthritis Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Rheumatoid Arthritis Drugs Market Size and Analysis by Regions (2013-2018)
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Rheumatoid Arthritis Drugs Market by Type
  1.3.1 NSAIDs
  1.3.2 DMARDs
  1.3.3 Corticosteroids
  1.3.4 Analgesics
  1.3.5 Other
1.4 Rheumatoid Arthritis Drugs Market by End Users/Application
  1.4.1 Hospitals
  1.4.2 Clinics
  1.4.3 Home Care
  1.4.4 Other

2 GLOBAL RHEUMATOID ARTHRITIS DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Rheumatoid Arthritis Drugs Market Size (Value) by Players (2013-2018)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Merck
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.1.5 Recent Developments
3.2 Novartis
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.2.5 Recent Developments
3.3 Pfizer
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.3.5 Recent Developments
3.4 J&J
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.4.5 Recent Developments
3.5 BMS
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.5.5 Recent Developments
3.6 Abbvie
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.6.5 Recent Developments
3.7 Boehringer Ingelheim
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.7.5 Recent Developments
3.8 AstraZeneca
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.8.5 Recent Developments
3.9 MedImmune
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.9.5 Recent Developments
3.10 Takeda
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Rheumatoid Arthritis Drugs Revenue (Million USD) (2013-2018)
  3.10.5 Recent Developments
3.11 Biogen Idec
3.12 Celgene
3.13 Bristol-Myers Squibb
3.14 Celltrion

4 GLOBAL RHEUMATOID ARTHRITIS DRUGS MARKET SIZE BY TYPE AND APPLICATION (2013-2018)

4.1 Global Rheumatoid Arthritis Drugs Market Size by Type (2013-2018)
4.2 Global Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
4.3 Potential Application of Rheumatoid Arthritis Drugs in Future
4.4 Top Consumer/End Users of Rheumatoid Arthritis Drugs

5 UNITED STATES RHEUMATOID ARTHRITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Rheumatoid Arthritis Drugs Market Size (2013-2018)
5.2 United States Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2013-2018)
5.3 United States Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)

6 EU RHEUMATOID ARTHRITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Rheumatoid Arthritis Drugs Market Size (2013-2018)
6.2 EU Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2013-2018)
6.3 EU Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)

7 JAPAN RHEUMATOID ARTHRITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Rheumatoid Arthritis Drugs Market Size (2013-2018)
7.2 Japan Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2013-2018)
7.3 Japan Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)

8 CHINA RHEUMATOID ARTHRITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Rheumatoid Arthritis Drugs Market Size (2013-2018)
8.2 China Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2013-2018)
8.3 China Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)

9 INDIA RHEUMATOID ARTHRITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Rheumatoid Arthritis Drugs Market Size (2013-2018)
9.2 India Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2013-2018)
9.3 India Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)

10 SOUTHEAST ASIA RHEUMATOID ARTHRITIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Rheumatoid Arthritis Drugs Market Size (2013-2018)
10.2 Southeast Asia Rheumatoid Arthritis Drugs Market Size and Market Share by Players (2013-2018)
10.3 Southeast Asia Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2018-2025)

11.1 Global Rheumatoid Arthritis Drugs Market Size (Value) by Regions (2018-2025)
  11.1.1 United States Rheumatoid Arthritis Drugs Revenue and Growth Rate (2018-2025)
  11.1.2 EU Rheumatoid Arthritis Drugs Revenue and Growth Rate (2018-2025)
  11.1.3 Japan Rheumatoid Arthritis Drugs Revenue and Growth Rate (2018-2025)
  11.1.4 China Rheumatoid Arthritis Drugs Revenue and Growth Rate (2018-2025)
  11.1.5 India Rheumatoid Arthritis Drugs Revenue and Growth Rate (2018-2025)
  11.1.6 Southeast Asia Rheumatoid Arthritis Drugs Revenue and Growth Rate (2018-2025)
11.2 Global Rheumatoid Arthritis Drugs Market Size (Value) by Type (2018-2025)
11.3 Global Rheumatoid Arthritis Drugs Market Size by Application (2018-2025)

12 RHEUMATOID ARTHRITIS DRUGS MARKET DYNAMICS

12.1 Rheumatoid Arthritis Drugs Market Opportunities
12.2 Rheumatoid Arthritis Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Rheumatoid Arthritis Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Rheumatoid Arthritis Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) Status and Outlook (2013-2018)
Table Global Rheumatoid Arthritis Drugs Revenue (Million USD) Comparison by Regions (2013-2018)
Figure Global Rheumatoid Arthritis Drugs Market Share by Regions (2013-2018)
Figure United States Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure EU Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Japan Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure China Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure India Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018)
Table Global Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
Figure Global Rheumatoid Arthritis Drugs Revenue Market Share by Type in 2017
Figure NSAIDs Market Size (Million USD) and Growth Rate (2013-2018)
Figure DMARDs Market Size (Million USD) and Growth Rate (2013-2018)
Figure Corticosteroids Market Size (Million USD) and Growth Rate (2013-2018)
Figure Analgesics Market Size (Million USD) and Growth Rate (2013-2018)
Figure Other Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Rheumatoid Arthritis Drugs Market Share by Application in 2017
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Hospitals (2013-2018)
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Clinics (2013-2018)
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Home Care (2013-2018)
Figure Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate in Other (2013-2018)
Table Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table Merck Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Merck (2013-2018)
Figure Merck Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Novartis Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Novartis (2013-2018)
Figure Novartis Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Pfizer Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Pfizer (2013-2018)
Figure Pfizer Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table J&J Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of J&J (2013-2018)
Figure J&J Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table BMS Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of BMS (2013-2018)
Figure BMS Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Abbvie Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Abbvie (2013-2018)
Figure Abbvie Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2013-2018)
Figure Boehringer Ingelheim Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of AstraZeneca (2013-2018)
Figure AstraZeneca Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table MedImmune Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of MedImmune (2013-2018)
Figure MedImmune Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Takeda Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Takeda (2013-2018)
Figure Takeda Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Biogen Idec Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Biogen Idec (2013-2018)
Figure Biogen Idec Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Celgene Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Celgene (2013-2018)
Figure Celgene Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Bristol-Myers Squibb (2013-2018)
Figure Bristol-Myers Squibb Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Celltrion Basic Information List
Table Rheumatoid Arthritis Drugs Business Revenue (Million USD) of Celltrion (2013-2018)
Figure Celltrion Rheumatoid Arthritis Drugs Business Revenue Market Share (2013-2018)
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Product (2013-2018)
Figure Global Rheumatoid Arthritis Drugs Revenue Market Share (%) by Product (2013-2018)
Figure Global Rheumatoid Arthritis Drugs Market Share by Product in 2017
Table Global Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure Global Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application in 2017
Table Top Consumer/End Users of Rheumatoid Arthritis Drugs
Figure United States Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table United States Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure United States Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure United States Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table United States Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure United States Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure United States Rheumatoid Arthritis Drugs Market Size Share by Application in 2017
Figure EU Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table EU Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure EU Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure EU Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table EU Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure EU Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure EU Rheumatoid Arthritis Drugs Market Size Share by Application in 2017
Figure Japan Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Japan Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure Japan Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure Japan Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table Japan Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure Japan Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Japan Rheumatoid Arthritis Drugs Market Size Share by Application in 2017
Figure China Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table China Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure China Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure China Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table China Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure China Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure China Rheumatoid Arthritis Drugs Market Size Share by Application in 2017
Figure India Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table India Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure India Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure India Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table India Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure India Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure India Rheumatoid Arthritis Drugs Market Size Share by Application in 2017
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size (Million USD) and Growth Rate (2013-2018)
Table Southeast Asia Rheumatoid Arthritis Drugs Market Size (Million USD) by Players (2013-2018)
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size Share by Players in 2013
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size Share by Players in 2017
Table Southeast Asia Rheumatoid Arthritis Drugs Market Size by Application (2013-2018)
Figure Southeast Asia Rheumatoid Arthritis Drugs Revenue Market Share (%) by Application (2013-2018)
Figure Southeast Asia Rheumatoid Arthritis Drugs Market Size Share by Application in 2017
Figure Global Rheumatoid Arthritis Drugs Market Size and Growth Rate (2018-2025)
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Regions (2018-2025)
Figure Global Rheumatoid Arthritis Drugs Market Size Share (2018-2025)
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Regions in 2025
Figure United States Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure EU Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Japan Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure China Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure India Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Figure Southeast Asia Rheumatoid Arthritis Drugs Revenue (Million USD) and Growth Rate (2018-2025)
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Type (2018-2025)
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2018
Figure Global Rheumatoid Arthritis Drugs Market Size Share by Type in 2025
Table Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application (2018-2025)
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2018
Figure Global Rheumatoid Arthritis Drugs Market Size (Million USD) by Application in 2025